A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes. [electronic resource]
Producer: 20140825Description: ra1 p. digitalISSN:- 1937-9145
- Acetylcysteine -- pharmacology
- Animals
- Blood Vessels -- metabolism
- Cell Movement -- drug effects
- Cells, Cultured
- Diabetes Mellitus, Experimental -- genetics
- Dose-Response Relationship, Drug
- Endothelium, Vascular -- drug effects
- Free Radical Scavengers -- pharmacology
- Glucose -- pharmacology
- Golgi Apparatus -- drug effects
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Immunoblotting
- Ligands
- Mice
- Mice, Knockout
- Mice, Obese
- Mice, Transgenic
- Phosphorylation -- drug effects
- Reactive Oxygen Species -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.